Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling

Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments consider...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2014-10, Vol.9 (10), p.e108818-e108818
Hauptverfasser: Lee, Sangkyun, Rahnenführer, Jörg, Lang, Michel, De Preter, Katleen, Mestdagh, Pieter, Koster, Jan, Versteeg, Rogier, Stallings, Raymond L, Varesio, Luigi, Asgharzadeh, Shahab, Schulte, Johannes H, Fielitz, Kathrin, Schwermer, Melanie, Morik, Katharina, Schramm, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e108818
container_issue 10
container_start_page e108818
container_title PloS one
container_volume 9
creator Lee, Sangkyun
Rahnenführer, Jörg
Lang, Michel
De Preter, Katleen
Mestdagh, Pieter
Koster, Jan
Versteeg, Rogier
Stallings, Raymond L
Varesio, Luigi
Asgharzadeh, Shahab
Schulte, Johannes H
Fielitz, Kathrin
Schwermer, Melanie
Morik, Katharina
Schramm, Alexander
description Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).
doi_str_mv 10.1371/journal.pone.0108818
format Article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1609313969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7a99a75d80854110a1d4c93ea3186528</doaj_id><sourcerecordid>1610760014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c592t-ffb2a590e3740ea093d4916eac433f38c3d8c9b9e7def7232bd6bfb7f995bda73</originalsourceid><addsrcrecordid>eNptkluL1TAUhYsozjj6D0QDvvjSY9I0bfMiDIOXgQFB9Dns5tLmmCY1SY_47-3xdIYZ8SlhZ60veyerKF4SvCO0Je_2YYke3G4OXu8wwV1HukfFOeG0KpsK08f39mfFs5T2GDPaNc3T4qxiFWesYufFj6-hX1JGSTstsw0eBYMkeKkjSks82AM4lOzgIS9RJ2RimNBoh7HMYwzLMM5LRoP2YbISKciAlmT9gPKvUJrg1ArpE0yzW4vPiycGXNIvtvWi-P7xw7erz-XNl0_XV5c3pWS8yqUxfQWMY03bGmvAnKqak0aDrCk1tJNUdZL3XLdKm7aiVa-a3vSt4Zz1Clp6Ubw-cWcXktjeKQnSrChCecNXxfVJoQLsxRztBPG3CGDF30KIg4CYrXRatMA5tEx1uGM1IRiIqiWnGijpGlZ1K-v9dtvST1pJ7XME9wD68MTbUQzhIGrC128jK-DtBojh56JTFpNNUjsHXofl2DfBbYMxqVfpm3-k_5-uPqlkDClFbe6aIVgcs3PrEsfsiC07q-3V_UHuTLdhoX8AjtHE3A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1609313969</pqid></control><display><type>article</type><title>Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Lee, Sangkyun ; Rahnenführer, Jörg ; Lang, Michel ; De Preter, Katleen ; Mestdagh, Pieter ; Koster, Jan ; Versteeg, Rogier ; Stallings, Raymond L ; Varesio, Luigi ; Asgharzadeh, Shahab ; Schulte, Johannes H ; Fielitz, Kathrin ; Schwermer, Melanie ; Morik, Katharina ; Schramm, Alexander</creator><contributor>Androulakis, Ioannis P.</contributor><creatorcontrib>Lee, Sangkyun ; Rahnenführer, Jörg ; Lang, Michel ; De Preter, Katleen ; Mestdagh, Pieter ; Koster, Jan ; Versteeg, Rogier ; Stallings, Raymond L ; Varesio, Luigi ; Asgharzadeh, Shahab ; Schulte, Johannes H ; Fielitz, Kathrin ; Schwermer, Melanie ; Morik, Katharina ; Schramm, Alexander ; Androulakis, Ioannis P.</creatorcontrib><description>Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0108818</identifier><identifier>PMID: 25295525</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adenocarcinoma ; Algorithms ; Biology and Life Sciences ; Breast cancer ; Breast Neoplasms - mortality ; Cancer ; Children &amp; youth ; Clinical trials ; Computer and Information Sciences ; Datasets ; Genes ; Hematology ; Humans ; Kinases ; Lung cancer ; Medical prognosis ; Medical research ; Medicine and Health Sciences ; Models, Theoretical ; Neoplasms - mortality ; Neuroblastoma ; Neuroblastoma - mortality ; Oncology ; Pediatrics ; Physical Sciences ; Predictions ; Probability ; Proportional Hazards Models ; Research and Analysis Methods ; Robustness (mathematics) ; Signatures ; Single-nucleotide polymorphism ; Statistical analysis ; Survival</subject><ispartof>PloS one, 2014-10, Vol.9 (10), p.e108818-e108818</ispartof><rights>2014 Lee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 Lee et al 2014 Lee et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c592t-ffb2a590e3740ea093d4916eac433f38c3d8c9b9e7def7232bd6bfb7f995bda73</citedby><cites>FETCH-LOGICAL-c592t-ffb2a590e3740ea093d4916eac433f38c3d8c9b9e7def7232bd6bfb7f995bda73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190101/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190101/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25295525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Androulakis, Ioannis P.</contributor><creatorcontrib>Lee, Sangkyun</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Lang, Michel</creatorcontrib><creatorcontrib>De Preter, Katleen</creatorcontrib><creatorcontrib>Mestdagh, Pieter</creatorcontrib><creatorcontrib>Koster, Jan</creatorcontrib><creatorcontrib>Versteeg, Rogier</creatorcontrib><creatorcontrib>Stallings, Raymond L</creatorcontrib><creatorcontrib>Varesio, Luigi</creatorcontrib><creatorcontrib>Asgharzadeh, Shahab</creatorcontrib><creatorcontrib>Schulte, Johannes H</creatorcontrib><creatorcontrib>Fielitz, Kathrin</creatorcontrib><creatorcontrib>Schwermer, Melanie</creatorcontrib><creatorcontrib>Morik, Katharina</creatorcontrib><creatorcontrib>Schramm, Alexander</creatorcontrib><title>Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).</description><subject>Adenocarcinoma</subject><subject>Algorithms</subject><subject>Biology and Life Sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - mortality</subject><subject>Cancer</subject><subject>Children &amp; youth</subject><subject>Clinical trials</subject><subject>Computer and Information Sciences</subject><subject>Datasets</subject><subject>Genes</subject><subject>Hematology</subject><subject>Humans</subject><subject>Kinases</subject><subject>Lung cancer</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Models, Theoretical</subject><subject>Neoplasms - mortality</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - mortality</subject><subject>Oncology</subject><subject>Pediatrics</subject><subject>Physical Sciences</subject><subject>Predictions</subject><subject>Probability</subject><subject>Proportional Hazards Models</subject><subject>Research and Analysis Methods</subject><subject>Robustness (mathematics)</subject><subject>Signatures</subject><subject>Single-nucleotide polymorphism</subject><subject>Statistical analysis</subject><subject>Survival</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNptkluL1TAUhYsozjj6D0QDvvjSY9I0bfMiDIOXgQFB9Dns5tLmmCY1SY_47-3xdIYZ8SlhZ60veyerKF4SvCO0Je_2YYke3G4OXu8wwV1HukfFOeG0KpsK08f39mfFs5T2GDPaNc3T4qxiFWesYufFj6-hX1JGSTstsw0eBYMkeKkjSks82AM4lOzgIS9RJ2RimNBoh7HMYwzLMM5LRoP2YbISKciAlmT9gPKvUJrg1ArpE0yzW4vPiycGXNIvtvWi-P7xw7erz-XNl0_XV5c3pWS8yqUxfQWMY03bGmvAnKqak0aDrCk1tJNUdZL3XLdKm7aiVa-a3vSt4Zz1Clp6Ubw-cWcXktjeKQnSrChCecNXxfVJoQLsxRztBPG3CGDF30KIg4CYrXRatMA5tEx1uGM1IRiIqiWnGijpGlZ1K-v9dtvST1pJ7XME9wD68MTbUQzhIGrC128jK-DtBojh56JTFpNNUjsHXofl2DfBbYMxqVfpm3-k_5-uPqlkDClFbe6aIVgcs3PrEsfsiC07q-3V_UHuTLdhoX8AjtHE3A</recordid><startdate>20141008</startdate><enddate>20141008</enddate><creator>Lee, Sangkyun</creator><creator>Rahnenführer, Jörg</creator><creator>Lang, Michel</creator><creator>De Preter, Katleen</creator><creator>Mestdagh, Pieter</creator><creator>Koster, Jan</creator><creator>Versteeg, Rogier</creator><creator>Stallings, Raymond L</creator><creator>Varesio, Luigi</creator><creator>Asgharzadeh, Shahab</creator><creator>Schulte, Johannes H</creator><creator>Fielitz, Kathrin</creator><creator>Schwermer, Melanie</creator><creator>Morik, Katharina</creator><creator>Schramm, Alexander</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20141008</creationdate><title>Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling</title><author>Lee, Sangkyun ; Rahnenführer, Jörg ; Lang, Michel ; De Preter, Katleen ; Mestdagh, Pieter ; Koster, Jan ; Versteeg, Rogier ; Stallings, Raymond L ; Varesio, Luigi ; Asgharzadeh, Shahab ; Schulte, Johannes H ; Fielitz, Kathrin ; Schwermer, Melanie ; Morik, Katharina ; Schramm, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c592t-ffb2a590e3740ea093d4916eac433f38c3d8c9b9e7def7232bd6bfb7f995bda73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adenocarcinoma</topic><topic>Algorithms</topic><topic>Biology and Life Sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - mortality</topic><topic>Cancer</topic><topic>Children &amp; youth</topic><topic>Clinical trials</topic><topic>Computer and Information Sciences</topic><topic>Datasets</topic><topic>Genes</topic><topic>Hematology</topic><topic>Humans</topic><topic>Kinases</topic><topic>Lung cancer</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Models, Theoretical</topic><topic>Neoplasms - mortality</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - mortality</topic><topic>Oncology</topic><topic>Pediatrics</topic><topic>Physical Sciences</topic><topic>Predictions</topic><topic>Probability</topic><topic>Proportional Hazards Models</topic><topic>Research and Analysis Methods</topic><topic>Robustness (mathematics)</topic><topic>Signatures</topic><topic>Single-nucleotide polymorphism</topic><topic>Statistical analysis</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Sangkyun</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Lang, Michel</creatorcontrib><creatorcontrib>De Preter, Katleen</creatorcontrib><creatorcontrib>Mestdagh, Pieter</creatorcontrib><creatorcontrib>Koster, Jan</creatorcontrib><creatorcontrib>Versteeg, Rogier</creatorcontrib><creatorcontrib>Stallings, Raymond L</creatorcontrib><creatorcontrib>Varesio, Luigi</creatorcontrib><creatorcontrib>Asgharzadeh, Shahab</creatorcontrib><creatorcontrib>Schulte, Johannes H</creatorcontrib><creatorcontrib>Fielitz, Kathrin</creatorcontrib><creatorcontrib>Schwermer, Melanie</creatorcontrib><creatorcontrib>Morik, Katharina</creatorcontrib><creatorcontrib>Schramm, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Sangkyun</au><au>Rahnenführer, Jörg</au><au>Lang, Michel</au><au>De Preter, Katleen</au><au>Mestdagh, Pieter</au><au>Koster, Jan</au><au>Versteeg, Rogier</au><au>Stallings, Raymond L</au><au>Varesio, Luigi</au><au>Asgharzadeh, Shahab</au><au>Schulte, Johannes H</au><au>Fielitz, Kathrin</au><au>Schwermer, Melanie</au><au>Morik, Katharina</au><au>Schramm, Alexander</au><au>Androulakis, Ioannis P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-10-08</date><risdate>2014</risdate><volume>9</volume><issue>10</issue><spage>e108818</spage><epage>e108818</epage><pages>e108818-e108818</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25295525</pmid><doi>10.1371/journal.pone.0108818</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2014-10, Vol.9 (10), p.e108818-e108818
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1609313969
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adenocarcinoma
Algorithms
Biology and Life Sciences
Breast cancer
Breast Neoplasms - mortality
Cancer
Children & youth
Clinical trials
Computer and Information Sciences
Datasets
Genes
Hematology
Humans
Kinases
Lung cancer
Medical prognosis
Medical research
Medicine and Health Sciences
Models, Theoretical
Neoplasms - mortality
Neuroblastoma
Neuroblastoma - mortality
Oncology
Pediatrics
Physical Sciences
Predictions
Probability
Proportional Hazards Models
Research and Analysis Methods
Robustness (mathematics)
Signatures
Single-nucleotide polymorphism
Statistical analysis
Survival
title Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Robust%20selection%20of%20cancer%20survival%20signatures%20from%20high-throughput%20genomic%20data%20using%20two-fold%20subsampling&rft.jtitle=PloS%20one&rft.au=Lee,%20Sangkyun&rft.date=2014-10-08&rft.volume=9&rft.issue=10&rft.spage=e108818&rft.epage=e108818&rft.pages=e108818-e108818&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0108818&rft_dat=%3Cproquest_plos_%3E1610760014%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1609313969&rft_id=info:pmid/25295525&rft_doaj_id=oai_doaj_org_article_7a99a75d80854110a1d4c93ea3186528&rfr_iscdi=true